0.70Open0.91Pre Close6 Volume113 Open Interest2.50Strike Price420.00Turnover190.18%IV-1.84%PremiumJul 19, 2024Expiry Date0.76Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8720Delta0.2417Gamma3.95Leverage Ratio-0.0130Theta0.0004Rho3.45Eff Leverage0.0010Vega
CureVac Stock Discussion
Benzinga· 1 min ago
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas Therapeutics.
First instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent liti...
loading...
No comment yet